Inventor · disambiguated record
Pjotr Knyazev
Also filed as: KNYAZEV PJOTR
6 granted patents·2 pending applications·55 citations·filing 1999–2012
82Inventor score
Top patents by PatentIndex Score
8 records- 0190US7297774B2Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancerMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Nov 20, 2007·26 cites·3 claims
- 0285US8043806B2Method of diagnosing an RTK-hyperfunction induced disorderMAX PLANCK GESELLSCHAFT·Filed 2010·Granted Oct 25, 2011·7 cites·7 claims
- 0380US7678372B2Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancerMAX PLANCK GESELLSCHAFT·Filed 2003·Granted Mar 16, 2010·7 cites·11 claims
- 0464US6770742B1Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancerMAX PLANCK GESELLSCHAFT·Filed 1999·Granted Aug 3, 2004·15 cites·1 claims
- 0552US9206130B2Quinoline derivatives as AXL kinase inhibitorsULLRICH AXEL·Filed 2009·Granted Dec 8, 2015·0 cites·9 claims
- 0650US8277802B2Diagnosis and prevention of cancer cell invasionULLRICH AXEL·Filed 2003·Granted Oct 2, 2012·0 cites·9 claims
- 0746US2011033482A1Her3 as a determinant for the prognosis of melanomaMAX PLANCK GESELLSCHAFT·Filed 2009·Application pending·0 cites
- 0838US2013084300A1Diagnosis and prevention of cancer cell invasionULLRICH AXEL·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pjotr Knyazev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →